Suppr超能文献

HIV-1 G 到 A 超突变和限制在非允许性 T 细胞系 CEM2n 中的内源性起源。

Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.

机构信息

Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, Minnesota, United States of America.

出版信息

PLoS Pathog. 2012;8(7):e1002800. doi: 10.1371/journal.ppat.1002800. Epub 2012 Jul 12.

Abstract

The DNA deaminase APOBEC3G converts cytosines to uracils in retroviral cDNA, which are immortalized as genomic strand G-to-A hypermutations by reverse transcription. A single round of APOBEC3G-dependent mutagenesis can be catastrophic, but evidence suggests that sublethal levels contribute to viral genetic diversity and the associated problems of drug resistance and immune escape. APOBEC3G exhibits an intrinsic preference for the second cytosine in a 5'CC dinucleotide motif leading to 5'GG-to-AG mutations. However, an additional hypermutation signature is commonly observed in proviral sequences from HIV-1 infected patients, 5'GA-to-AA, and it has been attributed controversially to one or more of the six other APOBEC3 deaminases. An unambiguous resolution of this problem has been difficult to achieve, in part due to dominant effects of protein over-expression. Here, we employ gene targeting to dissect the endogenous APOBEC3 contribution to Vif-deficient HIV-1 restriction and hypermutation in a nonpermissive T cell line CEM2n. We report that APOBEC3G-null cells, as predicted from previous studies, lose the capacity to inflict 5'GG-to-AG mutations. In contrast, APOBEC3F-null cells produced viruses with near-normal mutational patterns. Systematic knockdown of other APOBEC3 genes in an APOBEC3F-null background revealed a significant contribution from APOBEC3D in promoting 5'GA-to-AA hypermutations. Furthermore, Vif-deficient HIV-1 restriction was strong in parental CEM2n and APOBEC3D-knockdown cells, partially alleviated in APOBEC3G- or APOBEC3F-null cells, further alleviated in APOBEC3F-null/APOBEC3D-knockdown cells, and alleviated to the greatest extent in APOBEC3F-null/APOBEC3G-knockdown cells revealing clear redundancy in the HIV-1 restriction mechanism. We conclude that endogenous levels of APOBEC3D, APOBEC3F, and APOBEC3G combine to restrict Vif-deficient HIV-1 and cause the hallmark dinucleotide hypermutation patterns in CEM2n. Primary T lymphocytes express a similar set of APOBEC3 genes suggesting that the same repertoire may be important in vivo.

摘要

APOBEC3G 是一种 DNA 脱氨酶,可将逆转录病毒 cDNA 中的胞嘧啶转化为尿嘧啶,从而将其固定为基因组链的 G 到 A 超突变。APOBEC3G 依赖性诱变的单个循环可能是灾难性的,但有证据表明,亚致死水平有助于病毒遗传多样性,并导致耐药性和免疫逃逸等相关问题。APOBEC3G 对 5'CC 二核苷酸基序中的第二个胞嘧啶表现出内在的偏好,导致 5'GG 到 AG 突变。然而,在感染 HIV-1 的患者的前病毒序列中通常观察到另一种超突变特征,即 5'GA 到 AA,并且有争议地归因于六种其他 APOBEC3 脱氨酶之一或多种。由于蛋白过表达的主导作用,这个问题的明确解决一直很困难。在这里,我们采用基因靶向技术来剖析内源性 APOBEC3 对 Vif 缺陷型 HIV-1 限制和 CEM2n 非许可性 T 细胞系中的超突变的贡献。我们报告说,正如先前的研究预测的那样,APOBEC3G 缺失细胞丧失了施加 5'GG 到 AG 突变的能力。相比之下,APOBEC3F 缺失细胞产生的病毒具有近乎正常的突变模式。在 APOBEC3F 缺失背景下系统敲低其他 APOBEC3 基因表明,APOBEC3D 显著促进 5'GA 到 AA 超突变。此外,Vif 缺陷型 HIV-1 在亲本 CEM2n 和 APOBEC3D 敲低细胞中的限制很强,在 APOBEC3G 或 APOBEC3F 缺失细胞中部分缓解,在 APOBEC3F 缺失/APOBEC3D 敲低细胞中进一步缓解,在 APOBEC3F 缺失/APOBEC3G 敲低细胞中缓解到最大程度,表明 HIV-1 限制机制存在明显的冗余。我们得出结论,内源性水平的 APOBEC3D、APOBEC3F 和 APOBEC3G 共同限制 Vif 缺陷型 HIV-1 并导致 CEM2n 中标志性的二核苷酸超突变模式。原代 T 淋巴细胞表达相似的 APOBEC3 基因集,表明相同的基因库在体内可能很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e182/3395617/79ffbf729479/ppat.1002800.g001.jpg

相似文献

1
Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
PLoS Pathog. 2012;8(7):e1002800. doi: 10.1371/journal.ppat.1002800. Epub 2012 Jul 12.
2
Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
J Virol. 2017 Jan 18;91(3). doi: 10.1128/JVI.02230-16. Print 2017 Feb 1.
3
Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.
Virology. 2014 Feb;450-451:49-54. doi: 10.1016/j.virol.2013.11.041. Epub 2013 Dec 20.
5
HIV-1 restriction by endogenous APOBEC3G in the myeloid cell line THP-1.
J Gen Virol. 2019 Jul;100(7):1140-1152. doi: 10.1099/jgv.0.001276. Epub 2019 May 30.
6
APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo.
Curr Biol. 2004 Aug 10;14(15):1385-91. doi: 10.1016/j.cub.2004.06.050.
7
Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies.
Virology. 2019 Jan 15;527:21-31. doi: 10.1016/j.virol.2018.11.004. Epub 2018 Nov 15.
8
APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
J Virol. 2016 Apr 14;90(9):4681-4695. doi: 10.1128/JVI.03275-15. Print 2016 May.
9

引用本文的文献

1
HIV-1 latency: From acquaintance to confidant.
J Virus Erad. 2025 May 20;11(2):100597. doi: 10.1016/j.jve.2025.100597. eCollection 2025 Jun.
2
Overview of host-directed antiviral targets for future research and drug development.
Acta Pharm Sin B. 2025 Apr;15(4):1723-1751. doi: 10.1016/j.apsb.2025.03.011. Epub 2025 Mar 8.
3
APOBEC3-Related Editing and Non-Editing Determinants of HIV-1 and HTLV-1 Restriction.
Int J Mol Sci. 2025 Feb 12;26(4):1561. doi: 10.3390/ijms26041561.
4
Hypermut 3: identifying specific mutational patterns in a defined nucleotide context that allows multistate characters.
Bioinform Adv. 2025 Feb 10;5(1):vbaf025. doi: 10.1093/bioadv/vbaf025. eCollection 2025.
6
Potential Role of APOBEC3 Family Proteins in SARS-CoV-2 Replication.
Viruses. 2024 Jul 16;16(7):1141. doi: 10.3390/v16071141.
7
Structural insights into PPP2R5A degradation by HIV-1 Vif.
Nat Struct Mol Biol. 2024 Oct;31(10):1492-1501. doi: 10.1038/s41594-024-01314-6. Epub 2024 May 24.
10
Multiple lineages of monkeypox virus detected in the United States, 2021-2022.
Science. 2022 Nov 4;378(6619):560-565. doi: 10.1126/science.add4153. Epub 2022 Oct 20.

本文引用的文献

1
APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells.
PLoS Pathog. 2011 Sep;7(9):e1002221. doi: 10.1371/journal.ppat.1002221. Epub 2011 Sep 22.
2
Endogenous APOBEC3B restricts LINE-1 retrotransposition in transformed cells and human embryonic stem cells.
J Biol Chem. 2011 Oct 21;286(42):36427-37. doi: 10.1074/jbc.M111.251058. Epub 2011 Aug 30.
4
Identification of a single amino acid required for APOBEC3 antiretroviral cytidine deaminase activity.
J Virol. 2011 Jun;85(11):5691-5. doi: 10.1128/JVI.00243-11. Epub 2011 Mar 23.
5
Analysis of human APOBEC3H haplotypes and anti-human immunodeficiency virus type 1 activity.
J Virol. 2011 Apr;85(7):3142-52. doi: 10.1128/JVI.02049-10. Epub 2011 Jan 26.
6
Stably expressed APOBEC3F has negligible antiviral activity.
J Virol. 2010 Nov;84(21):11067-75. doi: 10.1128/JVI.01249-10. Epub 2010 Aug 11.
7
Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.
J Virol. 2010 Oct;84(19):10209-19. doi: 10.1128/JVI.00632-10. Epub 2010 Aug 4.
8
Moderate influence of human APOBEC3F on HIV-1 replication in primary lymphocytes.
J Virol. 2010 Sep;84(18):9613-7. doi: 10.1128/JVI.02630-09. Epub 2010 Jun 30.
9
Regulation of mRNA translation and stability by microRNAs.
Annu Rev Biochem. 2010;79:351-79. doi: 10.1146/annurev-biochem-060308-103103.
10
The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity.
J Virol. 2010 Aug;84(16):7961-9. doi: 10.1128/JVI.00754-10. Epub 2010 Jun 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验